Literature DB >> 23354623

WTAP regulates migration and invasion of cholangiocarcinoma cells.

Hong-Jae Jo1, Hye-Eun Shim, Myoung-Eun Han, Hyun-Jung Kim, Ki-Sun Kim, Sungmin Baek, Kyung-Un Choi, Gi-Yeong Hur, Sae-Ock Oh.   

Abstract

BACKGROUND: Wilms' tumor 1-associating protein (WTAP) is a nuclear protein that has been associated with the regulation of proliferation and apoptosis. Although its dynamic expression and physiological functions in vascular cells have been reported, its expression and roles in cholangiocarcinoma cells are poorly characterized.
METHODS: To examine the expression of WTAP in patient tissues, we performed immunohistochemistry. To examine motility of cholangiocarcinoma cells, we employed Boyden chamber, wound healing and Matrigel invasion assays, and a liver xenograft model.
RESULTS: Immunohistochemistry in patient tissues showed WTAP overexpression in cholangiocarcinoma tissues and correlation of WTAP expression with metastasis of cholangiocarcinoma cells. Overexpression or knockdown of WTAP significantly increased or decreased the motility of cholangiocarcinoma cells. Moreover, WTAP overexpression or knockdown significantly increased or decreased tumorigenicity of cholangiocarcinoma cells in an orthotopic xenograft model. Furthermore, microarray study showed that WTAP induce the expressions of MMP7, MMP28, cathepsin H and Muc1.
CONCLUSION: WTAP is overexpressed in cholangiocarcinoma and regulates motility of cholangiocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354623     DOI: 10.1007/s00535-013-0748-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  46 in total

1.  Proteomic analysis of interchromatin granule clusters.

Authors:  Noriko Saitoh; Chris S Spahr; Scott D Patterson; Paula Bubulya; Andrew F Neuwald; David L Spector
Journal:  Mol Biol Cell       Date:  2004-05-28       Impact factor: 4.138

2.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

3.  L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.

Authors:  Jeong-Ki Min; Jin-Man Kim; Shengjin Li; Jung Whoi Lee; Hyunho Yoon; Chun Jeih Ryu; Soung Hoo Jeon; Jae-Hyek Lee; Jin Young Kim; Hee Kwan Yoon; Young Kwan Lee; Bong-Hui Kim; Yeon Sung Son; Hong Seo Choi; Nam-Kyu Lim; Dae-Ghon Kim; Hyo Jeong Hong
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

4.  K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy.

Authors:  Tse-Ching Chen; Yi-Yin Jan; Ta-Sen Yeh
Journal:  Ann Surg Oncol       Date:  2012-07       Impact factor: 5.344

5.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry.

Authors:  Yoko Ukita; Masako Kato; Tadashi Terada
Journal:  J Hepatol       Date:  2002-06       Impact factor: 25.083

7.  Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA.

Authors:  Keiko Horiuchi; Michihisa Umetani; Takashi Minami; Hiroto Okayama; Shinji Takada; Masayuki Yamamoto; Hiroyuki Aburatani; Patrick C Reid; David E Housman; Takao Hamakubo; Tatsuhiko Kodama
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

8.  Neurotransmitter γ-aminobutyric acid-mediated inhibition of the invasive ability of cholangiocarcinoma cells.

Authors:  Qiang Huang; Chenhai Liu; Cheng Wang; Yuanguo Hu; Lujun Qiu; Peng Xu
Journal:  Oncol Lett       Date:  2011-03-04       Impact factor: 2.967

Review 9.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.

Authors:  K Araki; T Shimura; H Suzuki; S Tsutsumi; W Wada; T Yajima; T Kobayahi; N Kubo; H Kuwano
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

View more
  42 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP.

Authors:  Ling Zhang; Bijay Khadka; Jieying Wu; Yashu Feng; Bing Long; Ruozhi Xiao; Jiajun Liu
Journal:  Onco Targets Ther       Date:  2021-09-24       Impact factor: 4.147

3.  Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic Cancer.

Authors:  Ji-Li Xu
Journal:  Dig Dis Sci       Date:  2022-07-20       Impact factor: 3.487

4.  Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.

Authors:  Mahafujul Islam Quadery Tonmoy; Atqiya Fariha; Ithmam Hami; Kumkum Kar; Hasan Al Reza; Newaz Mohammed Bahadur; Md Shahadat Hossain
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 5.  Role of m6A modification in female infertility and reproductive system diseases.

Authors:  Jinyu Chen; Yiwei Fang; Ying Xu; Haotong Sun
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

6.  Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle.

Authors:  Keiko Horiuchi; Takeshi Kawamura; Hiroko Iwanari; Riuko Ohashi; Makoto Naito; Tatsuhiko Kodama; Takao Hamakubo
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

7.  WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Bing-Qi Li; Shuai Huang; Qian-Qian Shao; Jian Sun; Li Zhou; Lei You; Tai-Ping Zhang; Quan Liao; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

8.  Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.

Authors:  Zhuo Xi; Ping Wang; Yixue Xue; Chao Shang; Xiaobai Liu; Jun Ma; Zhiqing Li; Zhen Li; Min Bao; Yunhui Liu
Journal:  Oncotarget       Date:  2017-04-11

9.  Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma.

Authors:  Xiang-de Shi; Xian-Huan Yu; Wen-Rui Wu; Xiao-Lin Xu; Jie-Yu Wang; Lei-Bo Xu; Rui Zhang; Chao Liu
Journal:  Oncotarget       Date:  2016-10-25

10.  Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.

Authors:  Jingyuan Tang; Feng Wang; Gong Cheng; Shuhui Si; Xi Sun; Jie Han; Hao Yu; Wei Zhang; Qiang Lv; Ji-Fu Wei; Haiwei Yang
Journal:  J Exp Clin Cancer Res       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.